Olympus Labs UK

Preparing this page.

The page frame is ready. Current product and OpenLab information is loading here.

← Back to lab record

OPENLAB · SOURCE CONNECTION

Janoshik Analytical report 28939

Product: HALO
Batch: OL2209
Analysed: 18 April 2023

The laboratory source and supporting documents for this lab record.

Open original asset ↗Open laboratory source ↗

Fit · complete source image · Use zoom controls, then scroll inside the image to inspect detail.

Reading Halo’s purity and quantity results

Olympus Labs UK reports >90% chromatographic purity for the Halodrol raw material. This is a qualified compound-purity statement: it reports a lower bound, not an exact percentage or a result for the finished capsule.

Janoshik report 28939 separately identifies Halodrol and reports 34.70 mg in the tested sample from batch OL2209. Purity and quantity describe different measurements; neither value replaces the other, and the percentage alone does not establish a pass or fail against a universal purity threshold.

The unassigned chromatogram row showing 0.00 is not a zero-dose finding. The signed report’s 34.70 mg result remains the quantity observation.

Printed label declarations

These fields describe the supplied label artwork. Laboratory observations retain their own sample basis and source-specific methods.

Inspect the product label ↗

Label alias: HALODROL
Label strength: 33.3 MG
Capsules: 90
Form: CAPSULES
Label class: PROHORMONE
Label formulation statement: LAB FORMULATED
Label testing statement: THIRD PARTY TESTED

Source SHA-256: 76593da9ad7eeda607ac46c76bfc1e820781add7a2a51c0c387df38c69689554

Loading lab records.

Preparing this page.

RAD-140

Janoshik Analytical report 28939

Janoshik report 28939

Loading lab records.

RAD-140

Janoshik Analytical report 28939

Janoshik report 28939